Male cancer survivors aged 25 through 50 years who received testosterone replacement had decreased body fat and increased muscle mass in a PLOS Medicine trial.
The study included 136 male survivors of testicular cancer, lymphoma, and leukemia who had borderline low testosterone (7–12 nmol/L). Participants were randomly assigned to receive testosterone (Tostran 2% gel) or placebo for 26 weeks.
Slomski A. Testosterone Improved Body Composition in Male Cancer Survivors. JAMA. 2020;323(4):301. doi:10.1001/jama.2019.22086
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: